Cargando…

Anaphylactic Reaction to Lymphazurin 1% during Breast Reconstruction Surgery: An Uncommon but Serious Complication

Lymphazurin 1% (isosulfan blue dye) is the most frequently used blue dye in the United States, and it is commonly used for sentinel node biopsy in breast cancer patients. Although cases of allergic reaction to lymphazurin have been reported in the general surgery literature, to our knowledge, no cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishna, Vikram, Muetterties, Corbin, DiNome, Maggie L., Tseng, Charles Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544393/
https://www.ncbi.nlm.nih.gov/pubmed/33133935
http://dx.doi.org/10.1097/GOX.0000000000003075
_version_ 1783591847444086784
author Krishna, Vikram
Muetterties, Corbin
DiNome, Maggie L.
Tseng, Charles Y.
author_facet Krishna, Vikram
Muetterties, Corbin
DiNome, Maggie L.
Tseng, Charles Y.
author_sort Krishna, Vikram
collection PubMed
description Lymphazurin 1% (isosulfan blue dye) is the most frequently used blue dye in the United States, and it is commonly used for sentinel node biopsy in breast cancer patients. Although cases of allergic reaction to lymphazurin have been reported in the general surgery literature, to our knowledge, no cases of an adverse reaction to isosulfan blue have been reported in the plastic surgery literature. We describe a case of an intraoperative biphasic anaphylactic reaction to isosulfan blue in a female patient undergoing bilateral mastectomy and immediate bilateral DIEP breast reconstruction. The severity of her anaphylactic reaction required that we stop flap dissection and abort the reconstruction. Although an allergic reaction is uncommon, recognizing the signs of an acute hypersensitivity reaction is critical to good outcomes in these situations. Given the volume of combined breast oncologic and breast reconstruction surgeries and the increasing number of vascularized lymph node transfer and lymphovenous anastomosis performed annually, it is essential for the plastic surgeon to be cognizant of this rare hypersensitivity reaction.
format Online
Article
Text
id pubmed-7544393
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-75443932020-10-29 Anaphylactic Reaction to Lymphazurin 1% during Breast Reconstruction Surgery: An Uncommon but Serious Complication Krishna, Vikram Muetterties, Corbin DiNome, Maggie L. Tseng, Charles Y. Plast Reconstr Surg Glob Open Breast Lymphazurin 1% (isosulfan blue dye) is the most frequently used blue dye in the United States, and it is commonly used for sentinel node biopsy in breast cancer patients. Although cases of allergic reaction to lymphazurin have been reported in the general surgery literature, to our knowledge, no cases of an adverse reaction to isosulfan blue have been reported in the plastic surgery literature. We describe a case of an intraoperative biphasic anaphylactic reaction to isosulfan blue in a female patient undergoing bilateral mastectomy and immediate bilateral DIEP breast reconstruction. The severity of her anaphylactic reaction required that we stop flap dissection and abort the reconstruction. Although an allergic reaction is uncommon, recognizing the signs of an acute hypersensitivity reaction is critical to good outcomes in these situations. Given the volume of combined breast oncologic and breast reconstruction surgeries and the increasing number of vascularized lymph node transfer and lymphovenous anastomosis performed annually, it is essential for the plastic surgeon to be cognizant of this rare hypersensitivity reaction. Lippincott Williams & Wilkins 2020-09-17 /pmc/articles/PMC7544393/ /pubmed/33133935 http://dx.doi.org/10.1097/GOX.0000000000003075 Text en Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Breast
Krishna, Vikram
Muetterties, Corbin
DiNome, Maggie L.
Tseng, Charles Y.
Anaphylactic Reaction to Lymphazurin 1% during Breast Reconstruction Surgery: An Uncommon but Serious Complication
title Anaphylactic Reaction to Lymphazurin 1% during Breast Reconstruction Surgery: An Uncommon but Serious Complication
title_full Anaphylactic Reaction to Lymphazurin 1% during Breast Reconstruction Surgery: An Uncommon but Serious Complication
title_fullStr Anaphylactic Reaction to Lymphazurin 1% during Breast Reconstruction Surgery: An Uncommon but Serious Complication
title_full_unstemmed Anaphylactic Reaction to Lymphazurin 1% during Breast Reconstruction Surgery: An Uncommon but Serious Complication
title_short Anaphylactic Reaction to Lymphazurin 1% during Breast Reconstruction Surgery: An Uncommon but Serious Complication
title_sort anaphylactic reaction to lymphazurin 1% during breast reconstruction surgery: an uncommon but serious complication
topic Breast
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544393/
https://www.ncbi.nlm.nih.gov/pubmed/33133935
http://dx.doi.org/10.1097/GOX.0000000000003075
work_keys_str_mv AT krishnavikram anaphylacticreactiontolymphazurin1duringbreastreconstructionsurgeryanuncommonbutseriouscomplication
AT muettertiescorbin anaphylacticreactiontolymphazurin1duringbreastreconstructionsurgeryanuncommonbutseriouscomplication
AT dinomemaggiel anaphylacticreactiontolymphazurin1duringbreastreconstructionsurgeryanuncommonbutseriouscomplication
AT tsengcharlesy anaphylacticreactiontolymphazurin1duringbreastreconstructionsurgeryanuncommonbutseriouscomplication